Unmasking the expression of PD-L1 in Myeloid Derived Suppressor Cells: A case study in lung cancer to discover new drugs with specific on-target efficacy

• Laura G. Rico,
• Andrés Aguilar Hernández,
• Michael D. Ward,
• Jolene A. Bradford,
• Jordi Juncà,
• Rafael Rosell,
• Jordi Petriz

Affiliations

Laura G. Rico

Functional Cytomics Group, Institut de Recerca contra la Leucèmia Josep Carreras, IJC, Campus ICO-Germans Trias i Pujol, Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, UAB, Badalona, Barcelona, Catalonia, 08916, Spain

Andrés Aguilar Hernández

Quirón Dexeus University Hospital, Dr Rosell Oncology Institute, Barcelona, Spain

Michael D. Ward

Thermo Fisher Scientific, Eugene, OR, USA

Jolene A. Bradford

Thermo Fisher Scientific, Eugene, OR, USA

Jordi Juncà

Institut Català d'Oncologia, Hospital Germans Trias i Pujol (HGTiP), Badalona, Spain

Rafael Rosell

Quirón Dexeus University Hospital, Dr Rosell Oncology Institute, Barcelona, Spain; Institut Català d'Oncologia, Hospital Germans Trias i Pujol (HGTiP), Badalona, Spain; Corresponding author at: Quirón Dexeus University Hospital, Dr Rosell Oncology Institute, Barcelona, Spain.

Jordi Petriz

Functional Cytomics Group, Institut de Recerca contra la Leucèmia Josep Carreras, IJC, Campus ICO-Germans Trias i Pujol, Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, UAB, Badalona, Barcelona, Catalonia, 08916, Spain; Corresponding author.